From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa

The Lancet HIV

Volumn 4, Issue 5, 2017, Pages e223-e230

  Haber, Noah ^a,b   Tanser, Frank ^b,c,d   Bor, Jacob ^b,e,f   Naidu, Kevindra ^b,g   Mutevedzi, Tinofa ^b   Herbst, Kobus ^b   Porter, Kholoud ^b,h   Pillay, Deenan ^b,h   Bärnighausen, Till ^a,b,i  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SOUTH AFRICA; SURVIVAL ANALYSIS; TREATMENT RESPONSE; ADOLESCENT; BLOOD; CROSS-SECTIONAL STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LONGITUDINAL STUDY; MIDDLE AGED; PHYSIOLOGY; RURAL POPULATION; VIROLOGY; YOUNG ADULT;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RURAL POPULATION; SOUTH AFRICA; YOUNG ADULT;

EID: 85011115954     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(16)30224-7     Document Type: Article

References (35)

1. 1 WHO. Global update on HIV treatment 2013: results, impact, and opportunities, 2013, World Health Organization, Geneva.
2. 2 Alvarez-Uria, G, Pakam, R, Midde, M, Naik, PK, Entry, retention, and virological suppression in an HIV cohort study in India: description of the cascade of care and implications for reducing HIV-related mortality in low- and middle-income countries. Interdiscip Perspect Infect Dis 2013 (2013), 384–805.
3. 3 Gardner, EM, McLees, MP, Steiner, JF, Del Rio, C, Burman, WJ, The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52 (2011), 793–800.
4. 4 Kranzer, K, Govindasamy, D, Ford, N, Johnston, V, Lawn, SD, Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc 15 (2012), 17–383.
5. 5 Mugglin, C, Estill, J, Wandeler, G, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 17 (2012), 1509–1520.
6. 6 Rosen, S, Fox, MP, Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med, 8, 2011, e1001056.
7. 7 Kilmarx, PH, Mutasa-Apollo, T, Patching a leaky pipe: the cascade of HIV care. Curr Opin HIV AIDS 8 (2013), 59–64.
8. 8 Fox, MP, Rosen, S, Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health 15:suppl 1 (2010), 1–15.
9. 9 Bor, J, Herbst, AJ, Newell, ML, Bärnighausen, T, Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 339 (2013), 961–965.
10. 10 Egger, M, May, M, Chêne, G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360 (2002), 119–129.
11. 11 UNAIDS. Fact Sheet. http://www.unaids.org/en/resources/fact-sheet, 2016 (accessed Jan 17, 2017).
12. 12 Attia, S, Egger, M, Muller, M, Zwahlen, M, Low, N, Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23 (2009), 1397–1404.
13. 13 Rosen, S, Larson, B, Brennan, A, et al. Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment. PLoS One, 5, 2010, e12731.
14. 14 Bor, J, Tanser, F, Newell, ML, Bärnighausen, T, In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Affairs 31 (2012), 1459–1469.
15. 15 Cohen, MS, Chen, YQ, McCauley, M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365 (2011), 493–505.
16. 16 Siegfried, N, Uthman, OA, Rutherford, GW, Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev, 3, 2010 CD008272.
17. 17 Eaton, JW, Johnson, LF, Salomon, JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med, 9, 2012, e1001245.
18. 18 UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic, 2014, UNAIDS, Geneva.
19. 19 Haber, N, Pillay, D, Porter, K, Bärnighausen, T, Constructing the cascade of HIV care: methods for measurement. Curr Opin HIV AIDS 11 (2016), 102–108.
20. 20 Nosyk, B, Montaner, JSG, Colley, G, et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect Dis 14 (2014), 40–49.
21. 21 Nyirenda, M, Zaba, B, Bärnighausen, T, Hosegood, V, Newell, ML, Adjusting HIV prevalence for survey non-response using mortality rates: an application of the method using surveillance data from rural South Africa. PLoS One, 5, 2010, e12370.
22. 22 Zaidi, J, Grapsa, E, Tanser, F, Newell, ML, Bärnighausen, T, Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS 27 (2013), 2301–2305.
23. 23 Tanser, F, Hosegood, V, Bärnighausen, T, et al. Cohort profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol 37 (2008), 956–962.
24. 24 South African Department of Health. The South African Antiretroviral Treatment Guidelines 2013, 2014, Department of Health, Pretoria.
25. 25 Clouse, K, Pettifor, A, Maskew, M, et al. Initiating ART when presenting with higher CD4 counts results in reduced loss to follow-up in a resource-limited setting. AIDS 27 (2013), 645–650.
26. 26 South African Department of Health. The South African Antiretroviral Treatment Guidelines 2010, 2010, Department of Health, Pretoria.
27. 27 Houlihan, CF, Bland, RM, Mutevedzi, PC, et al. Cohort profile: Hlabisa HIV Treatment and Care Programme. Int J Epidemiol 40 (2011), 318–326.
28. 28 Kaplan, EL, Meier, P, Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958), 457–481.
29. 29 Ribaudo H, Lennox J, Currier J, et al. Virologic failure endpoint definition in clinical trials: is using HIV-1 RNA threshold <200 copies/mL better than <50 copies/mL? An analysis of ACTG studies. 16th Conference on Retroviruses and Opportunistic Infections; Montreal, QC, Canada; Feb 8–11, 2009; abstr 580.
30. 30 WHO. Metrics for monitoring the cascade of HIV testing, care and treatment services in Asia and the Pacific, 2014, World Health Organization Regional Office for the Western Pacific, Manila.
31. 31 Hallett, TB, Eaton, JW, A side door into care cascade for HIV-infected patients?. J Acquir Immune Defic Syndr 63:suppl 2 (2013), S228–S232.
32. 32 Nsanzimana, S, Kanters, S, Remera, E, et al. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme. Lancet HIV 2 (2015), e208–e215.
33. 33 Siedner, MJ, Ng, CK, Bassett, IV, Katz, IT, Bangsberg, DR, Tsai, AC, Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002–2013: a meta-analysis. Clin Infect Dis 60 (2015), 1120–1127.
34. 34 Larmarange, J, Mossong, J, Bärnighausen, T, Newell, ML, Participation dynamics in population-based longitudinal HIV surveillance in rural South Africa. PLoS One, 10, 2015, e0123345.
35. 35 McGovern, M, Herbst, K, Tanser, F, et al. Do gifts increase consent to home-based HIV testing? A difference-in-differences study in rural KwaZulu-Natal, South Africa. Int J Epidemiol, 2016, 10.1093/ije/dyw122 published online Dec 10.